Oppenheimer lowered the firm’s price target on Acrivon Therapeutics (ACRV) to $10 from $18 and keeps an Outperform rating on the shares ...

A popular theory frequently utilized by technical analysts suggests U.S. stocks could be headed for one last leg higher over ...

The End review: all down to the bunker for Joshua Oppenheimer’s bananas, post-apocalyptic musical - 3/5 Tilda Swinton and ...

Oppenheimer maintained its Outperform rating on AppLovin (NASDAQ:APP) while highlighting key points for the company from the ...

Written and Directed by Joshua Oppenheimer. Starring Tilda Swinton, George MacKay, Moses Ingram, Michael Shannon, Bronagh ...

Christopher Nolan’s Oppenheimer was that rare movie that was both a box office hit and a serious award winner. It also had ...

Meeting to be held on April 1 hosted by Oppenheimer.Light Up your Portfolio with Spark:Easily identify stocks' risks and opportunities.

Oppenheimer & Co. Inc. — a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that Ranjot Singh has joined the Firm as a Managing Director in ...

Christopher Nolan doesn't need an image to maintain; from Following (1998) to Oppenheimer (2023), fans know what's in store ...

Oppenheimer said on Wednesday it no longer expects growth in U.S. investment banking revenue this year and slashed its ...

Oppenheimer called the expected M&A rebound under the Trump administration “delayed or cancelled” and downgraded to "perform" ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...